[{"Assets_0_Q3_USD":370469000.0,"CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q3_USD":0.41,"EarningsPerShareBasic_3_Q3_USD":0.74,"EarningsPerShareDiluted_1_Q3_USD":0.4,"EarningsPerShareDiluted_3_Q3_USD":0.73,"Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":23614000.0,"NetIncomeLossConverted_1_Q3_USD":4720000.0,"NetIncomeLossConverted_3_Q3_USD":8553000.0,"OfficialName":"ANI Pharmaceuticals Inc.","RevenuesConverted_1_Q3_USD":48164000.0,"RevenuesConverted_3_Q3_USD":129556000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q3_USD":182801000.0,"Ticker":"ANIP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":11677000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":11666000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":11553000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":11542000.0,"filed":"20171102","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2017.0","name":"ANI PHARMACEUTICALS INC","period":"20170930","qtrs":"0","uom":"USD"}]